Evaluation of Aspirin and Clopidogrel resistance in patients with Acute Coronary Syndrome by using Adenosine Diposphate Test and Aspirin Test. - Wikidata - awgldk - TriplyDB

Evaluation of Aspirin and Clopidogrel resistance in patients with Acute Coronary Syndrome by using Adenosine Diposphate Test and Aspirin Test.

Evaluation of Aspirin and Clopidogrel resistance in patients with Acute Coronary Syndrome by using Adenosine Diposphate Test and Aspirin Test.

http://www.wikidata.org/entity/Q37257829

about

Single-center experience in the endovascular treatment of wide-necked intracranial aneurysms with a bridging intra-/extra-aneurysm implant (pCONus).Aspirin resistance in patients with acute coronary events: risk factors and prevalence as determined by whole blood multiple electrode aggregometry.

P2860

Q37399181-3C3C17AE-211E-4784-894E-C2CCF47B84D4 Q37526980-41D295F8-CCF2-4AD3-BC8D-2AEBD2EC252D

P2860

Evaluation of Aspirin and Clopidogrel resistance in patients with Acute Coronary Syndrome by using Adenosine Diposphate Test and Aspirin Test.

http://www.wikidata.org/entity/Q37257829

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Evaluation of Aspirin and Clop ...... osphate Test and Aspirin Test.

@en

Evaluation of Aspirin and Clop ...... osphate Test and Aspirin Test.

@nl

type

label

Evaluation of Aspirin and Clop ...... osphate Test and Aspirin Test.

@en

Evaluation of Aspirin and Clop ...... osphate Test and Aspirin Test.

@nl

prefLabel

Evaluation of Aspirin and Clop ...... osphate Test and Aspirin Test.

@en

Evaluation of Aspirin and Clop ...... osphate Test and Aspirin Test.

@nl

P1433

Q37257829-25958CED-7868-4E04-AC25-E5EEBAC4C62F

P1476

Q37257829-C8CC3CA9-1254-4648-AC3E-0C89A1E7CB48

P2093

Q37257829-00A2930B-C6CA-4B6E-BDDD-B12C3086C6CC

Q37257829-143D4FF9-AA32-479D-8EB5-94024670C560

Q37257829-3F9CE33D-2C11-43CB-A6A5-772FDA83AE5C

Q37257829-92AEF884-07D9-4FD0-94FF-F684482ACC0A

Q37257829-EF1F5B71-5BBD-45A9-9455-F9120AC2BFC5

Q37257829-FA135B55-4CB2-4A25-AC18-6791EFC5E15D

P2860

Q37257829-15BC94EA-9C41-435C-84B9-DFBA52DA168B

Q37257829-3935D299-F4EC-4CD3-B2D7-F4C2117C2E09

Q37257829-3A288CF9-4AA2-47A7-A11B-289EA6D43267

Q37257829-3A323B21-7267-40D4-993E-727CB0AE8393

Q37257829-3F46A8AA-9CDE-48AF-8751-D79FAA5DEF14

Q37257829-5610D6C0-A1CD-41F0-BC6B-8D73DCBC21DA

Q37257829-625E6056-72DB-4BBD-994F-9663AB8A5A03

Q37257829-64161E13-A999-41A4-8105-E949CE398C86

Q37257829-6E3DA8A7-EF24-40CF-9273-F213AF8B0DCE

Q37257829-77908936-E0D9-4118-B7E7-023BAE7B0966

P304

Q37257829-CD2C3F7D-6906-4042-B87B-68B922657815

P31

Q37257829-5407C806-580E-4780-83B3-B8C515595640

P356

Q37257829-FED9B02C-C9B2-41DD-AE5D-A5025B3E1DC3

P433

Q37257829-F5CB4E78-0683-4906-8846-948A1E1FD31F

P478

Q37257829-62C832F8-764D-4984-9F3E-903CC108ADDA

P577

Q37257829-E2F528D8-6774-409D-BE0A-6030D3D305B5

P5875

Q37257829-98EBF7E3-69A1-45CB-8638-C72EF64C9FA4

P698

Q37257829-8AA3ECB5-B05B-490C-AC1E-CD49B95EF0AF

P921

Q37257829-B1DD92F3-1DBC-4996-8AB2-EB3E79B36BFD

Q37257829-B73A7A7C-D86E-4404-8B67-FDB359F62621

P932

Q37257829-88B14095-4501-4162-BD7E-BAA7AEF359C0

P356

P1433

Pakistan Journal of Medical Sciences

P1476

Evaluation of Aspirin and Clop ...... osphate Test and Aspirin Test.

@en

P2093

A Syukur A

http://www.w3.org/2001/XMLSchema#string

Che Hassan Hh

http://www.w3.org/2001/XMLSchema#string

Ibrahim O

http://www.w3.org/2001/XMLSchema#string

Mm Rahman

http://www.w3.org/2001/XMLSchema#string

Oteh M

http://www.w3.org/2001/XMLSchema#string

S Fadilah W

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control

807 C/T Polymorphism of the glycoprotein Ia gene and pharmacogenetic modulation of platelet response to dual antiplatelet treatment

Low-dose aspirin increases aspirin resistance in patients with coronary artery disease

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

A new definition of aspirin non-responsiveness by platelet function analyzer-100 and its predictors

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

P304

97-102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12669/PJMS.291.2820

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259388314

http://www.w3.org/2001/XMLSchema#string

P698

24353516

http://www.w3.org/2001/XMLSchema#string

P921

P932

3809214

http://www.w3.org/2001/XMLSchema#string